Abstract:In the ever-evolving landscape of biomedical research, 3D Cell Culture (3DCC) systems have become essential for replicating in vivo environments and promoting more physiologically cellular interactions and microenvironment. 3DCC models can be beneficial in preclinical studies by reducing drug testing costs and minimizing the excessive use of animal models. This is especially significant in immuno-oncology research, where selecting an appropriate in vivo model poses challenges due to differences in protein structures across species and decisions regarding the use of humanized mouse models. 3DCC has the potential to represent fully human research models hence avoiding the complications of GvHD (graft versus host disease). In our study, we presented a potency of 3D co-culture of cancer RL95-2 endometrium cells and PBMCs and we indicated their use in further stages of immune-therapeutics testing. We also confirmed the phenomena that the 3D structures grow on top of the hydrogel making them accessible to both small molecules as well as large molecules like: antibodies, Antibody-Drug-Conjugates (ADCs), cytokines, CAR-T therapy, oncolytic viruses, that consists key technical advantage of our technics. We used protein-based hydrogel LifeGel® for creating 3D cell co-culture of cancer and immune cells. We demonstrated the new in vitro model on which the potency of immune checkpoint inhibitors, was verified. In our assay we verified the potential of therapeutic antibodies used in the clinic: atezolizumab (anti PD-L1) and onvatilimab (anti-VISTA), and also newly-developed bi-speccifics antibodies. After the co-culture with PBMCs in the presence of tested immunotherapeutics, the viability of cancer cells was evaluated using colorimetric assay. The morphological parameters of tumor spheroids after co-culture with immune cells were assessed using AnaSP software. It should be underlined that our 3DCC study showed more clinically predictive testing results when comparing to other pre-clinical models. Furthermore, we confirmed that not only immortalized cancer cells but also 3D structures of patient-derived tumoroids or patient-derived xenograft models may be used in co-culture with immune cells for drug screening and immuno-testing purposes. We also confirmed the phenomena that the 3D structures grow on top of the hydrogel making them accessible to both small molecules as well as large molecules like: antibodies, Antibody-Drug-Conjugates (ADCs), cytokines, CAR-T therapy, oncolytic viruses, etc. In the realm of cancer research, 3D cell cultures showcase a predictive power in assessing the mechanistic effects and anticancer effects of drugs that rivals traditional in vivo research models. LifeGels® biophysical parameters can be modified: hardness, density and elasticity, creating an environment adapted to every characteristic of cancer cells, making them accessible to immune cells evasion. The unique property of our approach is to use 3DCC in immune-oncology research as high-throughput screening (HTS), high-content analysis and fully-automated processing. Citation Format: Justyna Kocik-Krol, David Earnshaw, Marcin Krzykawski. The highly predictive 3D Cell Co-Culture Model for Immunotherapy studies [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy; 2024 Oct 18-21; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2024;12(10 Suppl) nr A020.

High-throughput formulation of reproducible 3D cancer microenvironments for drug testing in myelogenous leukemia

High-throughput formulation of reproducible 3D cancer microenvironments for drug testing in myeloid leukemia

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

Abstract 320: Perfused 3D Tri-Culture Breast Cancer Microtumors for Accurate Prediction of Drug Response

Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia

High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment

Abstract 4303: High-throughput 3D tumoroid models for immunotherapy and drug discovery

Microfabrication-Based Three-Dimensional (3-D) Extracellular Matrix Microenvironments for Cancer and Other Diseases

Tumor-Infiltration Mimicking Model of Contaminated Ovarian Tissue as an Innovative Platform for Advanced Cancer Research

Abstract A020: The highly predictive 3D Cell Co-Culture Model for Immunotherapy studies

Biophysical Model for High-Throughput Tumor and Epithelial Cell Co-Culture in Complex Biochemical Microenvironments

Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system

The critical role of the bone marrow stromal microenvironment for development of drug screening platforms in leukemia

A novel bioprinted microtumour model for studying acute-leukemia-cell- contaminated in ovarian tissue

Tumor Microenvironment Based on Extracellular Matrix Hydrogels for On-Chip Drug Screening

An Integrated Microfluidics Platform with High-Throughput Single-Cell Cloning Array and Concentration Gradient Generator for Efficient Cancer Drug Effect Screening.

High-throughput screening for drug discovery targeting the cancer cell-microenvironment interactions in hematological cancers

Enabling high throughput drug discovery in 3D cell cultures through a novel bioprinting workflow

Three-dimensional multicellular cell culture for anti-melanoma drug screening: focus on tumor microenvironment

High Throughput Scaffold-Based 3D Micro-Tumor Array for Efficient Drug Screening and Chemosensitivity Testing.

3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs